Study on the Prognostic Value of Aberrant Antigen in Patients With Acute B Lymphocytic Leukemia.

Clinical Lymphoma Myeloma and Leukemia(2019)

Cited 9|Views37
No score
Abstract
Therefore, in the construction of CAR-T cells in patients with R/R B-ALL, conventional CD19 can be combined with aberrant antigens such as CD123 to form CARs with bi-specific antigens or multi-specific antigens may achieve the purpose of improving efficacy. However, more clinical trials are needed.
More
Translated text
Key words
Aberrant antigen,Acute B lymphocytic leukemia,CAR-T cells,Flow Cytometry,Prognostic value
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined